1. Home
  2. RLAY vs CXM Comparison

RLAY vs CXM Comparison

Compare RLAY & CXM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$9.72

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Sprinklr Inc.

CXM

Sprinklr Inc.

HOLD

Current Price

$5.97

Market Cap

1.5B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLAY
CXM
Founded
2015
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
RLAY
CXM
Price
$9.72
$5.97
Analyst Decision
Strong Buy
Hold
Analyst Count
6
9
Target Price
$14.50
$9.89
AVG Volume (30 Days)
2.0M
2.4M
Earning Date
05-27-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
31.78
144.44
EPS
N/A
0.05
Revenue
$15,355,000.00
$796,394,000.00
Revenue This Year
N/A
$8.25
Revenue Next Year
$178.50
$3.44
P/E Ratio
N/A
$119.80
Revenue Growth
53.44
8.74
52 Week Low
$1.78
$5.12
52 Week High
$11.43
$9.69

Technical Indicators

Market Signals
Indicator
RLAY
CXM
Relative Strength Index (RSI) 59.25 50.58
Support Level $7.22 $5.19
Resistance Level $11.43 $8.06
Average True Range (ATR) 0.68 0.22
MACD 0.04 0.11
Stochastic Oscillator 43.23 85.15

Price Performance

Historical Comparison
RLAY
CXM

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

About CXM Sprinklr Inc.

Sprinklr Inc is engaged in enabling customer-facing teams, from Customer Service to Marketing, to collaborate across internal silos, communicate across digital channels, and leverage AI to deliver customer experiences at scale all on one unified AI-based platform. It focuses on empowering companies to deliver next-generation, unified engagement journeys that reimagine the customer's experience. Its products include Sprinklr Service, Sprinklr Social, Sprinklr Insights and Sprinklr Marketing. The company operates in the Americas, EMEA, and other countries. It derives maximum revenue from the Americas.

Share on Social Networks: